Bad Homburg, Germany

Lida Quinchia

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fresenius Kabi Deutschland Gmbh. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lida Quinchia. Retrieved from https://idiyas.com/inventor/lida-quinchia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lida Quinchia: Innovator in Anticancer Treatments

Introduction

Lida Quinchia is a notable inventor based in Bad Homburg, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on enhancing the efficacy of anticancer agents, which is crucial in the fight against solid tumors.

Latest Patents

Lida Quinchia holds a patent for a composition comprising EPA and DHA aimed at improving the effectiveness of anticancer agents. The patent details a formulation that includes an aqueous phase and an oil phase, with EPA and DHA present in a specific weight ratio. This composition is designed for use in the treatment of solid tumors, where the treatment involves administering both the composition and at least one anticancer agent. She has 1 patent to her name.

Career Highlights

Lida Quinchia is currently employed at Fresenius Kabi Deutschland GmbH, where she continues her research and development efforts. Her work is instrumental in advancing therapeutic options for cancer patients.

Collaborations

Some of her coworkers include Stefanie Honndorf and Silke Baasner, who contribute to her research initiatives and projects.

Conclusion

Lida Quinchia's innovative work in the field of anticancer treatments exemplifies the impact of research and development in medicine. Her contributions are paving the way for more effective cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…